CODX

Co-Diagnostics, Inc.

Company with tickers: CODX

CIK

1692415

CUSIP

189763204

Shares Outstanding

3,602,465

Website

https://www.codiagnostics.com

Investor Relations

https://ir.co-dx.com/

13F Activity (30d)

2 filings 2 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$30,000,000

as of 2022-03-31

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2023-12-31	$1,363,929	—	—	10-K, filed 2025-03-27
2022-12-31	$14,211,866	—	—	10-K, filed 2024-03-14

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2023-12-31	$159,673 Δ	—	—	10-K, filed 2025-03-27
2023-09-30	$166,326 Δ	—	—	10-Q, filed 2024-11-07
2023-06-30	$555,734 Δ	—	—	10-Q, filed 2024-08-08
2023-03-31	$482,196	—	—	10-Q, filed 2024-05-09
2022-12-31	$1,217,493 Δ	—	—	10-K, filed 2024-03-14
2022-09-30	$10,394,895 Δ	—	—	10-Q, filed 2023-11-09